生物兵器は生物学的戦争である.

Same author

[Algorithm for securing an unexpected difficult airway : User analysis on a simulator].

Der Anaesthesist·2017

Same author

Anthrax vaccine. Model of a response to the biologic warfare threat.

Infectious disease clinics of North America·1999

Same author

Variation in porcine red blood cell alpha-galactosyl expression and agglutination by human serum.

Transplantation proceedings·1998

Same author

A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.

Proceedings of the National Academy of Sciences of the United States of America·1996

Same author

Family practice in Saudi Arabia: chronic morbidity and quality of care.

International journal for quality in health care : journal of the International Society for Quality in Health Care·1996

Same author

Acromegaly.

Journal of the Mississippi State Medical Association·1985

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

生物兵器は生物学的戦争である.

関連する概念動画

[Algorithm for securing an unexpected difficult airway : User analysis on a simulator].

Anthrax vaccine. Model of a response to the biologic warfare threat.

Variation in porcine red blood cell alpha-galactosyl expression and agglutination by human serum.

A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.

Family practice in Saudi Arabia: chronic morbidity and quality of care.

Acromegaly.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

生物兵器は生物学的戦争である.

関連する概念動画

関連記事

[Algorithm for securing an unexpected difficult airway : User analysis on a simulator].

Anthrax vaccine. Model of a response to the biologic warfare threat.

Variation in porcine red blood cell alpha-galactosyl expression and agglutination by human serum.

A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene.

Family practice in Saudi Arabia: chronic morbidity and quality of care.

Acromegaly.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.